Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
4.410
-0.170 (-3.71%)
At close: Jan 31, 2025, 4:00 PM
4.400
-0.010 (-0.23%)
After-hours: Jan 31, 2025, 6:50 PM EST
Vanda Pharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for VNDA stock have an average target of 15.5, with a low estimate of 13 and a high estimate of 18. The average target predicts an increase of 251.47% from the current stock price of 4.41.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for VNDA stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 1 | 1 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +308.16% | Jan 28, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +308.16% | Jan 21, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +308.16% | Dec 23, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +308.16% | Oct 31, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $11 → $13 | Buy | Maintains | $11 → $13 | +194.78% | Aug 1, 2024 |
Financial Forecast
Revenue This Year
203.43M
from 192.64M
Increased by 5.60%
Revenue Next Year
290.60M
from 203.43M
Increased by 42.85%
EPS This Year
-0.33
from 0.04
EPS Next Year
0.21
from -0.33
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 215.4M | 391.4M | 535.2M |
Avg | 203.4M | 290.6M | 336.3M |
Low | 190.7M | 230.3M | 194.0M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | 11.8% | 92.4% | 84.2% |
Avg | 5.6% | 42.9% | 15.7% |
Low | -1.0% | 13.2% | -33.2% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -0.22 | 1.38 | 2.12 |
Avg | -0.33 | 0.21 | 1.03 |
Low | -0.37 | -0.41 | - |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | 922.7% |
Avg | - | - | 396.7% |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.